Page 1 of 108
EXAM 1: NR293 / NR 293 (LATEST 2025/ 2026
UPDATES STUDY BUNDLE PACKAGE WITH SOLUTIONS)
PHARMACOLOGY FOR NURSING PRACTICE |
QUESTIONS & ANSWERS | GRADE A | 100%
CORRECT (VERIFIED SOLUTIONS) - CHAMBERLAIN
Chemical name .....ANSWER.....Describes the drug's chemical
composition and molecular structure
Ex: (+/-)-2-(p-isobutylephenyl) propionic acid
Generic name .....ANSWER.....Nonproprietary name
-Given by the United States Adopted Names Council
-Used in most official drug compendiums to list drugs
Ex: Ibuprofen
Trade name .....ANSWER.....Proprietary name
,Page 2 of 108
-The drug has a registered trademark; use of the name is
restricted by the drug's patent owner (usually the manufacturer)
Ex: Motrin, others
____________ determines the rate of drug dissolution
.....ANSWER.....Dosage form
Drug dissolution .....ANSWER.....dissolving of solid dosage forms
and their absorption from the GI tract
Fastest drug absorption .....ANSWER.....Oral disintegration,
buccal tablets, oral soluable wafers
Slowest drug absorption .....ANSWER.....Enteric-coated tablets
Drug absorption from fastest to slowest .....ANSWER.....-Oral
disintegration, buccal tablets, oral soluable wafers
-Liquids, elixirs, and syrups
-Suspension solutions
-Powders
,Page 3 of 108
-Capsules
-Tablets
-Coated tablets
-Enteric-coated tablets
Absorption .....ANSWER.....Movement of a drug from its site of
administration into the blood stream for distribution to the tissues
Bioavailablitiy .....ANSWER.....Extent of drug absorption
Medication routes .....ANSWER.....-Enteral
-Parenteral
-Topical
Enteral .....ANSWER.....(GI tract)
-orally vs sublingual and buccal routes, G tube
-First pass effect, variable absorption
Patenteral .....ANSWER.....-Intravenous (IV)
, Page 4 of 108
-Intramuscular (IM)
Intravenous (IV) .....ANSWER.....Rapid onset
Avoid first pass effect
IV: Nursing considerations .....ANSWER.....Monitor drug
Check for compatibilities
Monitor IV site
Intramuscular (IM) .....ANSWER.....Subcutaneously
Topical .....ANSWER.....Avoid first-pass effect, except rectal
administration
-Transdermal
-Topical
Transdermal .....ANSWER.....Deliver constant amount
Slower onset, prolong duration
EXAM 1: NR293 / NR 293 (LATEST 2025/ 2026
UPDATES STUDY BUNDLE PACKAGE WITH SOLUTIONS)
PHARMACOLOGY FOR NURSING PRACTICE |
QUESTIONS & ANSWERS | GRADE A | 100%
CORRECT (VERIFIED SOLUTIONS) - CHAMBERLAIN
Chemical name .....ANSWER.....Describes the drug's chemical
composition and molecular structure
Ex: (+/-)-2-(p-isobutylephenyl) propionic acid
Generic name .....ANSWER.....Nonproprietary name
-Given by the United States Adopted Names Council
-Used in most official drug compendiums to list drugs
Ex: Ibuprofen
Trade name .....ANSWER.....Proprietary name
,Page 2 of 108
-The drug has a registered trademark; use of the name is
restricted by the drug's patent owner (usually the manufacturer)
Ex: Motrin, others
____________ determines the rate of drug dissolution
.....ANSWER.....Dosage form
Drug dissolution .....ANSWER.....dissolving of solid dosage forms
and their absorption from the GI tract
Fastest drug absorption .....ANSWER.....Oral disintegration,
buccal tablets, oral soluable wafers
Slowest drug absorption .....ANSWER.....Enteric-coated tablets
Drug absorption from fastest to slowest .....ANSWER.....-Oral
disintegration, buccal tablets, oral soluable wafers
-Liquids, elixirs, and syrups
-Suspension solutions
-Powders
,Page 3 of 108
-Capsules
-Tablets
-Coated tablets
-Enteric-coated tablets
Absorption .....ANSWER.....Movement of a drug from its site of
administration into the blood stream for distribution to the tissues
Bioavailablitiy .....ANSWER.....Extent of drug absorption
Medication routes .....ANSWER.....-Enteral
-Parenteral
-Topical
Enteral .....ANSWER.....(GI tract)
-orally vs sublingual and buccal routes, G tube
-First pass effect, variable absorption
Patenteral .....ANSWER.....-Intravenous (IV)
, Page 4 of 108
-Intramuscular (IM)
Intravenous (IV) .....ANSWER.....Rapid onset
Avoid first pass effect
IV: Nursing considerations .....ANSWER.....Monitor drug
Check for compatibilities
Monitor IV site
Intramuscular (IM) .....ANSWER.....Subcutaneously
Topical .....ANSWER.....Avoid first-pass effect, except rectal
administration
-Transdermal
-Topical
Transdermal .....ANSWER.....Deliver constant amount
Slower onset, prolong duration
